Lifeward (LFWD) Cash from Operations (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.93% |
| Dec 31, 2025 | 8.83% |
| Sep 30, 2025 | 0.74% |
| Jun 30, 2025 | 29.09% |
| Mar 31, 2025 | -38.57% |
| Dec 31, 2024 | 10.99% |
| Sep 30, 2024 | 20.62% |
| Jun 30, 2024 | 26.80% |
| Mar 31, 2024 | -71.12% |
| Dec 31, 2023 | 39.76% |
| Sep 30, 2023 | -112.32% |
| Jun 30, 2023 | 33.00% |
| Mar 31, 2023 | -33.73% |
| Dec 31, 2022 | 14.95% |
| Sep 30, 2022 | -25.40% |
| Jun 30, 2022 | 35.72% |
| Mar 31, 2022 | -122.45% |
| Dec 31, 2021 | -0.12% |
| Sep 30, 2021 | 19.07% |
| Jun 30, 2021 | 0.19% |
| Mar 31, 2021 | -29.09% |
| Dec 31, 2020 | 5.39% |
| Sep 30, 2020 | 18.61% |
| Jun 30, 2020 | 26.47% |
| Mar 31, 2020 | -20.92% |
| Dec 31, 2019 | -9.82% |
| Sep 30, 2019 | 11.72% |
| Jun 30, 2019 | 12.93% |
| Mar 31, 2019 | -63.58% |
| Dec 31, 2018 | 16.29% |
| Sep 30, 2018 | 23.16% |
| Jun 30, 2018 | 19.58% |
| Mar 31, 2018 | 7.27% |
| Dec 31, 2017 | 7.29% |
| Sep 30, 2017 | -13.14% |
| Jun 30, 2017 | 14.30% |
| Mar 31, 2017 | 7.91% |
| Dec 31, 2016 | 2.09% |
| Sep 30, 2016 | -1.69% |
| Jun 30, 2016 | 5.20% |
| Mar 31, 2016 | 2.87% |
| Dec 31, 2015 | -219.05% |
| Sep 30, 2015 | 2.42% |
| Jun 30, 2015 | 195.05% |
| Mar 31, 2015 | -126.88% |
| Dec 31, 2014 | -146.55% |
| Sep 30, 2014 | 53.16% |
| Dec 31, 2013 | -223.12% |